Skip to main content

MJFF Publications

5151 - 5160 of 7616 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • RESTRICTED
    Title: Algorithmic Complexity of EEG for Prognosis of Neurodegeneration in Idiopathic Rapid Eye Movement Behavior Disorder (RBD)
    Journal Name: Annals of Biomedical Engineering
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10439-018-02112-0
    Citation Count: 21
  • RESTRICTED
    Title: Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1286-2
    Citation Count: 63
  • RESTRICTED
    Title: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
    Journal Name: Journal of Experimental Medicine
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1084/jem.20180484
    Citation Count: 52
  • RESTRICTED
    Title: Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorder
    Journal Name: Brain Imaging and Behavior
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11682-018-9939-4
    Citation Count: 21
  • RESTRICTED
    Title: Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embr.201745680
    Citation Count: 42
  • RESTRICTED
    Title: Increased substantia nigra echogenicity in LRRK2 family members without mutations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27443
    Citation Count: 1
  • RESTRICTED
    Title: Validation of the MDS clinical diagnostic criteria for Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27362
    Best OA location URL:
    Citation Count: 176
  • RESTRICTED
    Title: Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-018-1313-4
    Best OA location URL:
    Citation Count: 22
  • RESTRICTED
    Title: Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1900-5
    Citation Count: 48
  • RESTRICTED
    Title: Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0062-4
    Citation Count: 61
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.